[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Intravenous Immunoglobulin (IVIg) Market Report 2017

November 2017 | 105 pages | ID: U170A703ECEEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Intravenous Immunoglobulin (IVIg) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Intravenous Immunoglobulin (IVIg) in these regions, from 2012 to 2022 (forecast).
United States Intravenous Immunoglobulin (IVIg) market competition by top manufacturers/players, with Intravenous Immunoglobulin (IVIg) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • CSL Behring
  • Grifols
  • Octapharma
  • Shire
  • ADMA Biologics
  • Bayer
  • Bharat Serum and Vaccines
  • Biotest
  • China Biologic Products
  • Hualan Biological Engineering
  • Kedrion Biopharma
  • Sanquin
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Neurology
  • Hematology
  • Immunology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Immunology
  • Oncology
  • Pulmonology
  • Rheumatology
  • Transplant
  • Neurology
  • Hematology
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Intravenous Immunoglobulin (IVIg) Market Report 2017

1 INTRAVENOUS IMMUNOGLOBULIN (IVIG) OVERVIEW

1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
1.2 Classification of Intravenous Immunoglobulin (IVIg) by Product Category
  1.2.1 United States Intravenous Immunoglobulin (IVIg) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Intravenous Immunoglobulin (IVIg) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Neurology
  1.2.4 Hematology
  1.2.5 Immunology
1.3 United States Intravenous Immunoglobulin (IVIg) Market by Application/End Users
  1.3.1 United States Intravenous Immunoglobulin (IVIg) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Immunology
  1.3.3 Oncology
  1.3.4 Pulmonology
  1.3.5 Rheumatology
  1.3.6 Transplant
  1.3.7 Neurology
  1.3.8 Hematology
  1.3.9 Others
1.4 United States Intravenous Immunoglobulin (IVIg) Market by Region
  1.4.1 United States Intravenous Immunoglobulin (IVIg) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
  1.4.3 Southwest Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
  1.4.5 New England Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
  1.4.6 The South Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
  1.4.7 The Midwest Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Intravenous Immunoglobulin (IVIg) (2012-2022)
  1.5.1 United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2022)
  1.5.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2022)

2 UNITED STATES INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Intravenous Immunoglobulin (IVIg) Average Price by Players/Suppliers (2012-2017)
2.4 United States Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
  2.4.1 United States Intravenous Immunoglobulin (IVIg) Market Concentration Rate
  2.4.2 United States Intravenous Immunoglobulin (IVIg) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Region (2012-2017)
3.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Region (2012-2017)
3.3 United States Intravenous Immunoglobulin (IVIg) Price by Region (2012-2017)

4 UNITED STATES INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2012-2017)
4.3 United States Intravenous Immunoglobulin (IVIg) Price by Type (2012-2017)
4.4 United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Application (2012-2017)
5.2 United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INTRAVENOUS IMMUNOGLOBULIN (IVIG) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 CSL Behring
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 CSL Behring Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Grifols
  6.2.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Octapharma
  6.3.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Shire
  6.4.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Shire Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 ADMA Biologics
  6.5.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bayer
  6.6.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bayer Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bharat Serum and Vaccines
  6.7.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Biotest
  6.8.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 China Biologic Products
  6.9.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 China Biologic Products Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Hualan Biological Engineering
  6.10.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Kedrion Biopharma
6.12 Sanquin

7 INTRAVENOUS IMMUNOGLOBULIN (IVIG) MANUFACTURING COST ANALYSIS

7.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Intravenous Immunoglobulin (IVIg) Sales Volume Forecast by Type (2017-2022)
11.3 United States Intravenous Immunoglobulin (IVIg) Sales Volume Forecast by Application (2017-2022)
11.4 United States Intravenous Immunoglobulin (IVIg) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Intravenous Immunoglobulin (IVIg)
Figure United States Intravenous Immunoglobulin (IVIg) Market Size (K MT) by Type (2012-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Type (Product Category) in 2016
Figure Neurology Product Picture
Figure Hematology Product Picture
Figure Immunology Product Picture
Figure United States Intravenous Immunoglobulin (IVIg) Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application in 2016
Figure Immunology Examples
Table Key Downstream Customer in Immunology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Pulmonology Examples
Table Key Downstream Customer in Pulmonology
Figure Rheumatology Examples
Table Key Downstream Customer in Rheumatology
Figure Transplant Examples
Table Key Downstream Customer in Transplant
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Hematology Examples
Table Key Downstream Customer in Hematology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Intravenous Immunoglobulin (IVIg) Market Size (Million USD) by Region (2012-2022)
Figure The West Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2012-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Intravenous Immunoglobulin (IVIg) Sales Share by Players/Suppliers
Figure 2017 United States Intravenous Immunoglobulin (IVIg) Sales Share by Players/Suppliers
Figure United States Intravenous Immunoglobulin (IVIg) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Intravenous Immunoglobulin (IVIg) Revenue Share by Players/Suppliers
Figure 2017 United States Intravenous Immunoglobulin (IVIg) Revenue Share by Players/Suppliers
Table United States Market Intravenous Immunoglobulin (IVIg) Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Intravenous Immunoglobulin (IVIg) Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Intravenous Immunoglobulin (IVIg) Market Share of Top 3 Players/Suppliers
Figure United States Intravenous Immunoglobulin (IVIg) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Intravenous Immunoglobulin (IVIg) Product Category
Table United States Intravenous Immunoglobulin (IVIg) Sales (K MT) by Region (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Share by Region (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Share by Region (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2016
Table United States Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Revenue Share by Region (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in 2016
Table United States Intravenous Immunoglobulin (IVIg) Price (USD/MT) by Region (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Share by Type (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Share by Type (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2016
Table United States Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type (2012-2017)
Figure Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type in 2016
Table United States Intravenous Immunoglobulin (IVIg) Price (USD/MT) by Types (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Type (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application (2012-2017)
Table United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2016
Table United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2012-2017)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2012-2017)
Table CSL Behring Basic Information List
Table CSL Behring Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure CSL Behring Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure CSL Behring Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure CSL Behring Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table Grifols Basic Information List
Table Grifols Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Grifols Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure Grifols Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure Grifols Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table Octapharma Basic Information List
Table Octapharma Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Octapharma Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure Octapharma Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure Octapharma Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shire Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure Shire Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure Shire Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table ADMA Biologics Basic Information List
Table ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure ADMA Biologics Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure Bayer Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure Bayer Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table Bharat Serum and Vaccines Basic Information List
Table Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table Biotest Basic Information List
Table Biotest Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biotest Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure Biotest Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure Biotest Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table China Biologic Products Basic Information List
Table China Biologic Products Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure China Biologic Products Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure China Biologic Products Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure China Biologic Products Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2012-2017)
Figure Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales Market Share in United States (2012-2017)
Figure Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Revenue Market Share in United States (2012-2017)
Table Kedrion Biopharma Basic Information List
Table Sanquin Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Table Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Players/Suppliers in 2016
Table Major Buyers of Intravenous Immunoglobulin (IVIg)
Table Distributors/Traders List
Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Price (USD/MT) Trend Forecast (2017-2022)
Table United States Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) Forecast by Type in 2022
Table United States Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) Forecast by Application in 2022
Table United States Intravenous Immunoglobulin (IVIg) Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Intravenous Immunoglobulin (IVIg) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories